These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17707558)

  • 1. Quality control of routine, experimental and real-time aged diphtheria toxoids by in vitro analytical techniques.
    Metz B; Jiskoot W; Mekkes D; Kingma R; Hennink WE; Crommelin DJ; Kersten GF
    Vaccine; 2007 Sep; 25(39-40):6863-71. PubMed ID: 17707558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines.
    Metz B; Jiskoot W; Hennink WE; Crommelin DJ; Kersten GF
    Vaccine; 2003 Dec; 22(2):156-67. PubMed ID: 14615142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physicochemical and immunochemical assays for monitoring consistent production of tetanus toxoid.
    Metz B; Tilstra W; van der Put R; Spruit N; van den Ijssel J; Robert J; Hendriksen C; Kersten G
    Biologicals; 2013 Jul; 41(4):231-7. PubMed ID: 23726755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro determination of antigen quality: biosensor analysis and fluorescence spectroscopy.
    Kersten GF; Jiskoot W; Hazendonk T; Beuvery EC
    Dev Biol Stand; 1998; 92():295-300. PubMed ID: 9554284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro approach in quality control of toxoid vaccines.
    Leenaars PP; Kersten GF; de Bruijn ML; Hendriksen CF
    Vaccine; 2001 Mar; 19(17-19):2729-33. PubMed ID: 11257416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the conformation, hydrophobicity, and model membrane interactions of diphtheria toxin to those of formaldehyde-treated toxin (diphtheria toxoid): formaldehyde stabilization of the native conformation inhibits changes that allow membrane insertion.
    Paliwal R; London E
    Biochemistry; 1996 Feb; 35(7):2374-9. PubMed ID: 8652579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural perturbation of diphtheria toxoid upon adsorption to aluminium hydroxide adjuvant.
    Régnier M; Metz B; Tilstra W; Hendriksen C; Jiskoot W; Norde W; Kersten G
    Vaccine; 2012 Nov; 30(48):6783-8. PubMed ID: 23000120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Vero cell method for potency testing of diphtheria vaccines.
    Winsnes R; Sesardic D; Daas A; Rigsby P
    Dev Biol (Basel); 2002; 111():141-8. PubMed ID: 12678233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vero cell assay validation of an alternative to the Ph. Eur. diphtheria potency tests.
    Gommer AM
    Dev Biol Stand; 1996; 86():217-24. PubMed ID: 8785952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calibration of replacement international standard and European Pharmacopoeia Biological Reference Preparation for Diphtheria Toxoid, Adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Gaines-Das R
    Biologicals; 2001 Jun; 29(2):107-22. PubMed ID: 11580215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Granule-accumulation in VERO cells used for determination of antitoxin titration by micro cell culture method: II. Nature of granules and influence on the potency testing of diphtheria toxoid].
    Yasuda S; Komiya T; Takahashi M; Kameyama S; Matuhashi T
    Rinsho Byori; 1993 May; 41(5):609-13. PubMed ID: 8350535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of detoxification process on toxicity and foreign protein of tetanus toxoid and diphtheria toxoid.
    Long Z; Wei C; Ross R; Luo X; Ma X; Qi Y; Chai R; Cao J; Huang M; Bo T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Sep; 1207():123377. PubMed ID: 35905569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2).
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2006 Nov; 2006(1):73-88. PubMed ID: 17270133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in animal usage for potency testing of diphtheria and tetanus toxoids.
    Stainer DW; Jakus CM; Sparkes JD
    Dev Biol Stand; 1986; 65():241-4. PubMed ID: 3556773
    [No Abstract]   [Full Text] [Related]  

  • 15. Consistency testing of diphtheria and tetanus to replace potency testing for lot release.
    Kreeftenberg JG
    Dev Biol (Basel); 2002; 111():291-8. PubMed ID: 12678252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical evaluation of numbers of animals to be used in vaccine potency testing: a practical approach.
    Akkermans AM; Hendriksen CF
    Dev Biol Stand; 1999; 101():255-60. PubMed ID: 10566799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of the Toxin Binding Inhibition (ToBI) test for the estimation of the potency of the diphtheria component of vaccines.
    Hendriksen CF; van den Gun JW; Kreeftenberg JG
    J Biol Stand; 1989 Jul; 17(3):241-7. PubMed ID: 2793876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CHEMICAL STRUCTURE OF DIPHTHERIAL TOXIN AND TOXOID. I. COMPARATIVE ANALYSIS OF TOXIN AND TOXOID AMINO ACIDS].
    ISKIERKO J
    Med Dosw Mikrobiol; 1964; 16():207-15. PubMed ID: 14198036
    [No Abstract]   [Full Text] [Related]  

  • 19. Potency assay of diphtheria and tetanus toxoids some theoretical and practical considerations.
    Lyng J
    Dev Biol Stand; 1986; 64():47-50. PubMed ID: 3792657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of the protein content of diphtheria and tetanus toxoids by the Biuret method during production of combined vaccines.
    Shrivastaw KP; Jhamb SS; Kumar A
    Biologicals; 1995 Mar; 23(1):61-3. PubMed ID: 7619438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.